Lapatinib

From Ganfyd

Jump to: navigation, search

Lapatinib (GW572016) is a drug with dual actions: it selectively inhibits both epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases.[1] Promising drug in treatment of breast cancer.[2][3]


References

This article is a work in progress. Please feel free to contribute to it.

Personal tools